Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Sotera Health (SHC)

Nasdaq Health Care Health Care Services S&P MidCap 400
$16.01
+0.14 (+0.88%)
Close of Nov 06, 2026 · end-of-day data
Source: Sotera Health's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 04, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$778.33M$818.16M$931.48M$1.00B$1.05B$1.10B$1.16B
Cost of revenue$382.90M$374.59M$412.81M$446.68M$472.13M$498.15M$518.08M
Gross profit$395.43M$443.57M$518.67M$557.00M$577.16M$602.29M$645.53M
Selling, general & admin$147.48M$178.53M$198.16M$245.71M$236.67M$242.63M$252.76M
Operating income$183.60M$206.02M$256.73M$248.35M$276.69M$297.63M—
Pre-tax income-$916.00K-$38.86M$175.72M-$243.11M$106.03M$113.87M$147.51M
Income tax$19.51M-$1.37M$58.59M-$9.54M$54.65M$69.48M$69.56M
Net income-$20.85M-$38.62M$116.88M-$233.57M$51.38M$44.40M$77.95M
EBITDA$250.30M$269.32M$320.93M$312.65M$353.29M$381.93M—
EPS (basic)$-0.09$-0.16$0.41$-0.83$0.18$0.16$0.27
EPS (diluted)$-0.09$-0.16$0.41$-0.83$0.18$0.16$0.27
Diluted shares232.40M237.70M279.38M280.10M283.22M284.91M286.42M
Gross margin50.8%54.2%55.7%55.5%55.0%54.7%55.5%
Operating margin23.6%25.2%27.6%24.7%26.4%27.0%—
Net margin-2.7%-4.7%12.5%-23.3%4.9%4.0%6.7%

Balance sheet

fiscal years · USD
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$63.02M$102.45M$106.92M$395.21M$296.41M$277.24M$344.62M
Receivables—$91.73M$108.18M$118.48M$147.70M$140.33M$139.33M
Inventory—$34.09M$54.29M$37.15M$48.32M$49.16M$54.38M
Total current assets—$315.01M$345.96M$645.01M$557.24M$526.04M$613.41M
Goodwill$1.04B$1.12B$1.12B$1.10B$1.11B$1.08B$1.10B
Total assets—$2.76B$2.79B$3.12B$3.13B$3.07B$3.26B
Total current liabilities—$140.60M$161.16M$791.57M$230.65M$191.00M$249.58M
Short-term debt—$0$0$197.12M$4.80M$14.80M$13.97M
Long-term debt—$1.82B$1.74B$1.75B$2.22B$2.21B$2.13B
Total debt—$1.82B$1.74B$1.94B$2.23B$2.22B$2.14B
Total liabilities—$2.31B$2.20B$2.77B$2.69B$2.67B$2.66B
Shareholders' equity-$641.13M$452.30M$586.10M$350.24M$443.73M$404.91M$606.03M

Cash flow

fiscal years · USD
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$149.04M$120.58M$281.55M$277.96M-$147.73M$224.16M$287.19M
Capital expenditures$57.26M$53.51M$102.16M$182.38M$214.97M$179.07M$138.02M
Free cash flow$91.78M$67.08M$179.38M$95.58M-$362.71M$45.09M$149.18M
Investing cash flow-$57.26M-$158.69M-$159.83M-$181.90M-$214.91M-$179.00M-$135.14M
Financing cash flow-$126.03M$73.43M-$117.29M$197.76M$265.96M-$50.56M-$100.53M
Dividends paid$691.17M$0$0————
Share buybacks$0$34.00M$0$0———
Stock-based compensation$6.88M$10.99M$13.87M$21.21M$32.24M$36.78M$30.88M
Depreciation & amortization$66.70M$63.30M$64.20M$64.30M$76.60M$84.30M$94.90M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.